• 한국간호교육학회지
• /
• 제16권2호
• /
• pp.330-338
• /
• 2010

Purpose: This study was conducted to investigate performance of self-monitoring of blood glucose and the utilization of results for people with type II diabetes. Method: Data was collected from 177 patients with type II diabetes using a questionnaire from August to September, 2009. Result: Most participants performed self-monitoring of blood glucose in the correct way while some misused the lancet or test strips. In the utilization of results for self-monitoring blood glucose data, 62% of participants always recorded the data, 46% always understood the cause for hyperglycemia or hypoglycemia, 25% changed their diet, 23% regulated their exercise-amount, and 11% of participants adjusted the drug dosage. There were significant differences in the performance of self-monitoring of blood glucose and the utilization of results according to the characteristics in the self-monitoring subjects such as awareness of HbA1c, target fasting glucose level, target fasting glucose level 2 hours after meal etc. Conclusion: Systemic self-monitoring of blood glucose education which includes the utilization of self-monitoring of blood glucose needs to be developed for type II diabetic patients.

• Clinical and Experimental Pediatrics
• /
• 제58권8호
• /
• pp.301-308
• /
• 2015

Purpose: We evaluated three blood glucose self-monitoring for measuring whole blood glucose levels in preterm and low-birth-weight infants. Methods: Between December 1, 2012 and March 31, 2013, 230 blood samples were collected from 50 newborns, who weighed, ${\leq}2,300g$ or were ${\leq}36$ weeks old, in the the neonatal intensive care unit of Eulji University Hospital. Three blood glucose self-monitoring (A: Precision Pcx, Abbott; B: One-Touch Verio, Johnson & Johnson; C: LifeScan SureStep Flexx, Johnson & Johnson) were used for the blood glucose measurements. The results were compared to those obtained using laboratory equipment (D: Advia chemical analyzer, Siemens Healthcare Diagnostics Inc.). Results: The correlation coefficients between laboratory equipment and the three blood glucose self-monitoring (A, B, and C) were found to be 0.888, 0.884, and 0.900, respectively. For glucose levels ${\leq}60mg/dL$, the correlation coefficients were 0.674, 0.687, and 0.679, respectively. For glucose levels>60 mg/dL, the correlation coefficients were 0.822, 0.819, and 0.839, respectively. All correlation coefficients were statistically significant. And the values from the blood glucose self-monitoring were not significantly different from the value of the laboratory equipment, after correcting for each device's average value (P>0.05). When using laboratory equipment (blood glucose ${\leq}60mg/dL$), each device had a sensitivity of 0.458, 0.604, and 0.688 and a specificity of 0.995, 0.989, and 0.989, respectively. Conclusion: Significant difference is not found between three blood glucose self-monitoring and laboratory equipment. But correlation between the measured values from blood glucose self-monitoring and laboratory equipment is lower in preterm or low-birth-weight infants than adults.

• 한국임상수의학회지
• /
• 제27권4호
• /
• pp.392-396
• /
• 2010

Blood glucose curves in the management for diabetic patients have several limitations including intermittent assessment of blood glucose concentration, hospitalization, patient restraint, and repeated phlebotomy. The aim of this study was to apply and evaluate a wireless continuous glucose monitoring system (CGMS) in healthy dogs. Subcutaneous interstitial glucose concentrations in 7 dogs were continuously monitored and recorded by wireless CGMS. During induced hyperglycemia, the interstitial glucose concentrations were compared with whole blood glucose concentrations measured by glucometer and serum glucose concentrations measured by automated chemistry analyzer, respectively. There were no significant differences among interstitial, whole blood and serum glucose concentrations. The interstitial glucose concentrations had a good correlation to serum glucose concentrations. The real-time wireless CGMS is a valuable tool for monitoring system of glucose concentrations in dogs. Use of the CGMS for diabetic patients will provide accurate information over traditional blood glucose curves.

• 한국염색가공학회지
• /
• 제16권2호
• /
• pp.47-51
• /
• 2004

A differential refractive index detector was used for monitoring glucose contents in textile processing solutions. The sensitivity of the device was high enough to measure 0.05％ aqueous glucose solution that could not be measured by normal refractive index measurement. The device was set to monitor glucose concentration continuously in real time by measuring differential refractive index and calibrated by standard glucose solutions in a range of 0.1 to 1.0%. The possibility of industrial application of the device was demonstrated by real-time monitoring of glucose concentration in textile processing solutions such as desizing bath and cellulase treatment bath. Both of solutions contained glucose as a major degraded product. The device would be able to control the weight loss of cellulosic fiber during cellulase treatment since the amount of degraded products in a processing bath is proportional to its weight loss.

• Clinical and Experimental Pediatrics
• /
• 제61권10호
• /
• pp.307-314
• /
• 2018

The incidence of type 1 diabetes mellitus (T1DM) in children and adolescents is increasing worldwide. Combined effects of genetic and environmental factors cause T1DM, which make it difficult to predict whether an individual will inherit the disease. Due to the level of self-care necessary in T1DM maintenance, it is crucial for pediatric settings to support achieving optimal glucose control, especially when adolescents are beginning to take more responsibility for their own health. Innovative insulin delivery systems, such as continuous subcutaneous insulin infusion (CSII), and noninvasive glucose monitoring systems, such as continuous glucose monitoring (CGM), allow patients with T1DM to achieve a normal and flexible lifestyle. However, there are still challenges in achieving optimal glucose control despite advanced technology in T1DM administration. In this article, disease prediction and current management of T1DM are reviewed with special emphasis on biomarkers of pancreatic ${\beta}-cell$ stress, CSII, glucose monitoring, and several other adjunctive therapies.

• 대한의용생체공학회:의공학회지
• /
• 제23권5호
• /
• pp.397-403
• /
• 2002

뇨당 측정 시스템은 소변 속의 글루코오스 농도를 측정함으로서 당뇨 수치를 모니터링하는 비침습적인 당뇨병 자가 진단 장치이다. 본 논문에서는 기존의 침습형 혈당측정방법의 불편성과 비색계를 이용한 뇨당 검사법의 단점을 보완한 뇨당 측정시스템을 설계하였다. 뇨당 측정시스템은 뇨당 측정용 화학센서, 신호검출부, 디지털 제어 및 신호분석부, 디스플레이부 및 전원부로 구성된다. 뇨당측정용 센서로는 재현성이 뛰어나고 다루기가 간편하며 저렴한 가격으로 대량 생산할 수, 있는 일회용 뇨당측정용 전류화학센서를 개발하였다. 설계한 뇨당 측정시스템의 성능을 평가하기 위하여 사람의 소변에 임의의 농도의 글루코오스 성분을 섞은 용액에 대하여 글루코오스 성분 분석시 사용되는 표준장비와의 비교분석을 통해서 글루코오스 농도 검출에 대한 신뢰성 평가를 수행하였다. 회귀분석에 기초한 신뢰성 평가를 수행한 결과 표준오차는 2.85282로 나타났다. 또한, 화학센서를 사용해서 측정하는 시스템을 평가 시 중요한 파라미터인 S.D(Standard Deviation)는 10%로서 임상적으로 유효한 15% 범주 내에 있음을 확인하였고, C.V(Coefficient of Validation)값은 ,5%이내이므로 혈당센서의 기준으로 평가해 볼때 만족하는 결과를 보였다.

• KSBB Journal
• /
• 제32권1호
• /
• pp.35-45
• /
• 2017

In this work the optical fiber glucose and lactate biosensors were developed by using fluorescent dye and enzyme immobilized on the end tip of an optical fiber. 3-Glycidyloxypropyl)methyldiethoxysilane (GPTMS), (3-Aminopropyl) trimethoxysilane (APTMS) and Methyltrimethoxysilane (MTMS) were used to immobilize glucose oxidase (GOD), lactate oxidase (LOD) and ruthenium(II) complex (tris(4,7-diphenyl-1,10-phenanthroline) ruthenium(II), $Ru(dpp)_3^{2+}$) as oxygen sensitive fluorescent dye. MTMS sol-gel was an excellent supporting material for the immobilization of $Ru(dpp)_3^{2+}$, GOD, and LOD on the optical fiber. Storage stability of the optical fiber glucose sensor was kept constant over 20 days, while the optical fiber lactate sensor had constant storage stability over 17 days. The optical fiber glucose and lactate biosensors also maintained good operational stability for 20 hours and 14 hours, respectively. The activities of the immobilized enzymes were most excellent at pH 7 and at $25^{\circ}C$. On-line monitoring of glucose and lactate in a simulated process was performed with the optical fiber glucose and lactate biosensors. On-line monitoring results were agreed with those of off-line data measured with high performance liquid chromatography (HPLC).

• 전자통신동향분석
• /
• 제36권5호
• /
• pp.9-20
• /
• 2021

A technology to replace the traditional blood sampling method for glucose monitoring has been sought for a long time. It is now possible to measure the blood glucose change rate continuously for more than 24 hours using a minimally invasive method that does not involve blood collection. Furthermore, various technology development efforts are being made for innovative diabetes management through intermittent or continuous blood glucose monitoring in a non-invasive manner. In this paper, we present an overview of diabetes and the need for continuous blood glucose measurement techniques., and then introduce various non-invasive blood glucose measurement techniques currently being studied. In addition, through research and analysis of the recent commercialization development status of minimally invasive, non-invasive, and wearable continuous blood glucose measurement technologies, we examine global development trends of future technologies.

• KSBB Journal
• /
• 제16권5호
• /
• pp.459-465
• /
• 2001

본 연구에서는 생물공정에서 주요 기질로 이용되는 글루코오스와 전분을 온라인 모니터링 하기 이하여 GOD, AMG를 이용한 흐름 주입분석(Flow Injection Analysis : FIA) 기술을 개발하였고, 효소활성 변화를 비교, 고찰하였다. 특히, epoxy 고분자 담체에 고정화된 COD-FIA와 AMG/GOD-FIA 장치의 성능을 조사하였고, FIA의 조작온도, pH, 운반용액의 첨가제, 염 그리고 각종 신진대사물질의 고정화된 GOD, AMG의 활성에 대한 영향을 소형 반응기내 글루코오스와 전분의 농도 변화를 온라인 모니터링하였다. GOD-FIA에 의한 온라인 모니터링 결과는 오프라인 분석과 비교적 잘 일치하였으며, AMG/GOD-FIA에의한 전분 농도의 온라인 모니터링은 단일 효소 반응기를 사용한 경우 두 개의 효소 반응기를 사용한 경우보다 더 효과적임을 알 수 있었다.

• Bulletin of the Korean Chemical Society
• /
• 제24권4호
• /
• pp.514-516
• /
• 2003